RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies.
Judge offers early win for Arbutus as Moderna vaccine patent spat heats up
A Delaware federal judge has sided with Arbutus’ interpretation of three patent claim terms in its case against Moderna, giving the biotech a small win